Chronic unpredictable stress enhances cocaine-conditioned place preference in type 1 cannabinoid receptor knockout mice

Behavioural Pharmacology

Volumn 19, Issue 5-6, 2008, Pages 575-581

  Miller, Laurence L ^a   Ward, Sara J ^b   Dykstra, Linda A ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Cannabinoid receptor; Chronic stress; Cocaine; Endocannabinoid; Knockout mouse; Type 1 cannabinoid receptor

Indexed keywords

CANNABINOID 1 RECEPTOR; COCAINE; ENDOCANNABINOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CHRONIC STRESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; GENOTYPE; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; STATISTICAL ANALYSIS; WILD TYPE; ANIMAL; AROUSAL; BAGG ALBINO MOUSE; BRAIN; COCAINE DEPENDENCE; CONDITIONED REFLEX; GENETICS; MENTAL STRESS; MOTOR ACTIVITY; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SOCIAL ENVIRONMENT;

ANIMALS; AROUSAL; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENOTYPE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL;

EID: 58149335562     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32830ded11     Document Type: Article

References (68)

1. Ahmed SH, Koob GF (1997). Cocaine-but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology 132:289-295.
2. Arevalo C, de Miguel R, Hernandez-Tristan R (2001). Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacol Biochem Behav 70:123-131.
3. Bambico FR, Katz N, Debonnel G, Gobbi G (2007). Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 27:13369-13370.
4. 1 receptor knockout mice. Life Sci 75:2959-2970.
5. Bekris S, Antoniou K, Daskas S, Papadopoulou-Daifoti Z (2005). Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res 161:45-59.
6. Benelli A, Filaferro M, Bertolini A, Genedani S (1999). Influence of S-adenosyl-L-methionine on chronic mild stress-induced anhedonia in castrated rats. Brit J Pharmacol 127:645-654.
7. 9-tetrahydrocannabinol. Psychopharmacology 163:111-117.
8. Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, Frau R, Trezza V, et al. (2006). Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31:2652-2659.
9. Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A et al. (2007). Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiat 62:1103-1110.
10. Chaperon F, Soubrie' P, Puech AJ, Thiebot MH (1998). Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology 135:324-332.
11. Cheer JF, Wassum KM, Sombers LS, Heien MLAV, Ariansen JL, Aragona BJ, et al. (2007). Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 27:791-795.
12. 1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 118:61-65.
13. Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grubler Y, et al. (2007). Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 148:1574-1581.
14. D'Aquila P, Monleon S, Borsini F, Brain P, Willner P (1997). Anti-hedonic actions of the novel serotonergic agent flibanserin, a potential rapidly acting antidepressant. Eur J Pharmacol 340:121-132.
15. De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, et al. (2001). A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7:1151-1154.
16. Erb S, Shaham Y, Stewart J (1996). Stress reinstates cocaine seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 128:408-412.
17. Filip M, Golda A, Zaniewska M, McCreary AC, Nowak E, Kolasiewicz W (2006). Involvement of cannabinoid CB(1) receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. Pharmacol Rep 58:806-819.
18. Genn RF, Tucci S, Marco EM, Viveros MP, File SE (2004). Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test. Pharmacol Biochem Behav 77: 567-573.
19. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, et al. (2005). Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci 102:18620-18625.
20. Goeders NE (2002). Stress and cocaine addiction. J Pharmacol Exp Ther 301:785-789.
21. Goeders NE, Guerin GF (1994). Non-contingent electric footshock facilitates the acquisition of intravenous cocaine self-administration. Psychopharmacology 114:63-70.
22. Goeders NE, Guerin GF (1996a). Role of corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology 64:337-348.
23. Goeders NE, Guerin GF (1996b). Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res 25:145-152.
24. Haile CN, GrandPre T, Kosten TA (2001). Chronic unpredictable stress, but not chronic predictable stress, enhances the sensitivity to the behavioral effects of cocaine in rats. Psychopharmacology 154:213-220.
25. 1 cannabinoid receptor on anxiety. Eur J Neurosci 16:1395-1398.
26. 1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 19:1906-1912.
27. 1-specific agents. Behav Pharmacol 15:299-304.
28. Haney M, Maccari S, LeMoal M, Simon H, Piazza PV (1995). Social stress increases the acquisition of cocaine self-administration in male and female rats. Brain Res 698:46-52.
29. 1 receptor activity elicits an antidepressant-like response in the rat forced swim test. Eur Neuropsychopharmacol 15:593-599.
30. Hill MN, Karacabeyli ES, Gorzalka BB (2007). Estrogen recruits the endocannabinoid system to modulate emotionality. Psychoneuroendocrinology 32: 350-357.
31. Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, Gorzalka BB (2005). Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 30:508-515.
32. 1 receptor knockout mice. Science 283:401-404.
33. Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR (1988). Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther 247:1046-1051.
34. Mantsch JR, Goeders NE (1999). Ketoconazole blocks the stressor-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine. Psychopharmacology 142:399-407.
35. Mantsch JR, Saphier D, Goeders NE (1998). Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type II glucocorticoid receptor agonist, dexamethasone. J Pharmacol Exp Ther 287:72-80.
36. Marco EM, Perez-Alvarez L, borcel E, Rubio M, Guaza C, Ambrosio E, et al. (2004). Involvement of 5-HT1A receptors in behavioral effects of the cannabinoid receptor agonist CP 55940 in male rats. Behav Pharmacol 15:21-27.
37. Marin S, Marco E, Bixcaia M, Fernandez B, Rubio M, Guaza C, et al. (2003). Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55940 in male rats. Pharmacol Biochem Behav 74:649-656.
38. Marinelli M, Piazza PV (2002). Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 16:387-394.
39. 1 knockout mice. Eur J Neurosci, 12:4038-4046.
40. 1 cannabinoid receptors in emotional behavior. Psychopharmacology 159:379-387.
41. 0McGregor IS, Dastur FN, McLellan RA, Brown RE (1996). Cannabinoid modulation of rat pup ultrasonic vocalizations. Eur J Pharmacol 313:43-49.
42. 1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology 40:918-926.
43. Miczek KA, Mutschler NH (1996). Activational effects of social stress on IV cocaine self-administration in rats. Psychopharmacology 128:256-264.
44. Muscat R, Papp M, Willner P (1992). Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology 109:433-438.
45. Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, et al. (1997). Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. NeuroReport 8:491-496.
46. Norwood CS, Cornish JL, Mallet PE, McGregor IS (2003). Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. Eur J Pharmacol 465:105-114.
47. Onaivi ES, Green MR, Martin BR (1990). Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253: 1002-1009.
48. Papp M, Willner P, Muscat R (1991). An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104:255-259.
49. Papp M, Lappas S, Muscat R, Willner P (1992). Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress. J Psychopharmacology 6:352-356.
50. Papp M, Muscat R, Willner P (1993). Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress. Psychopharmacology 110:152-158.
51. Patel S, Hillard CJ (2006). Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 218: 304-311.
52. Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ (2004). Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145:5431-5438.
53. Riedel G, Davies SN (2005). Cannabinoid function in learning, memory and plasticity. Handb Exp Pharmacol 168:445-477.
54. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, et al. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
55. Sinha R (2001). How does stress increase risk of drug abuse and relapse. Psychopharmacology 158:343-359.
56. Solinas M, Justinova Z, Goldberg SR, Tanda G (2006). Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J Neurochem 98:408-419.
57. Soria G, Mendizabal V, Tourino C, Robledo P, Ledent C, Parmentier M, et al. (2005). Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 30:1670-1680.
58. Tanda G, Munzar P, Goldberg SR (2000). Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3:1073-1074.
59. 1 receptors. Neuropharmacology 46:966-973.
60. 9-tetrahydrocannabinol and nicotine. Brit J Pharmacol 135:564-578.
61. B receptor antagonist. Psychopharmacology 131:79-85.
62. 1 receptor agonism. Behav Pharmacol 16:381-388.
63. 1 cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol 145:293-300.
64. Willner P (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90-110.
65. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93:358-364.
66. 1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropsychopharmacology 33:1735-1745.
67. 1 receptor knockout mice. Proc Natl Assoc Sci 96:5780-5785.
68. Zimmer A (1992). Manipulating the genome by homologous recombination in embryonic stem cells. Annu Rev Neurosci 15:115-137.